Citrus Compound Restores Youthful Function in Aging Liver

Peel an orange and you might be holding a tiny lifeline for an aging organ. Could a molecule tucked into citrus peel nudge tired livers back toward youth? A study published in npj Aging suggests it can—at least in mice.

Researchers led by Zhao-Qing Shen at National Yang Ming Chiao Tung University focused on hesperetin, a flavonoid abundant in lemons, limes and orange skins. Hesperetin has long surfaced in lab work for anti-inflammatory and neuroprotective hints, but this team chased a different lead: a longevity-linked gene called Cisd2 that helps preserve liver and metabolic health.

Here is the striking part. The team treated naturally old mice with a daily dose of hesperetin for five months. When they examined the livers, animals that received the compound showed Cisd2 levels similar to those in very young mice. Fatty deposits thinned. Cell damage and inflammation fell.

 Hesperetin restored Cisd2 levels in old mice to those seen in young animals and reversed multiple signs of liver aging.

Genome-wide RNA analysis added texture to the picture: gene activity in treated animals shifted toward a younger profile, reversing many age-associated expression changes. To test whether Cisd2 was essential, the researchers turned to mice engineered to lack the gene in hepatocytes. Those animals, already sickly by three months, failed to benefit from hesperetin, indicating the compound largely needs Cisd2 to exert its effects—though a few Cisd2-independent changes were observed.

Mechanistically, hesperetin seems to act through a chain of signaling that involves Hmgcs2 and PPARα, proteins that together boost Cisd2 activity. The team also looked at non-tumor liver tissue from 80 human patients and found that PPARα and CISD2 decline with age, a pattern that mirrors the mouse data and raises the possibility that the pathway is conserved in people.

That possibility comes with caveats. Mice are not humans, and dosage, safety and long-term effects need careful clinical testing. Still, the work frames hesperetin both as a molecular probe and as a candidate for functional-food strategies derived from citrus peel. If the signal holds up in trials, a humble peel—which most of us toss—could point the way to new interventions for age-related fatty liver disease and broader hepatic decline.

There is a long road from lab bench to medicine cabinet, but the next time you hold an orange, consider the chemistry wasted with the peel—and the questions it now raises about ageing, resilience and simple molecules with outsized potential.